EUVIMEDEUVIMED entdecken
Open Access

Computational Modeling of Effects of PKP2 Gene Therapy on Ventricular Conduction Properties in Arrhythmogenic Cardiomyopathy

Alessio Ostini, André G Kléber iD, Yoram Rudy iD, Jeffrey E Saffitz iD, Jan P Kucera iD

Circulation: Arrhythmia and Electrophysiology · 2025-05 · 18 (5)

DOI: 10.1161/circep.124.013658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025-05. Verfasst von Alessio Ostini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology (A.O., J.P.K.), University of Bern, Switzerland. Hauptthemen laut MEDLINE: Genetic Therapy, Plakophilins, Myocytes, Cardiac, Computer Simulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with arrhythmogenic cardiomyopathy due to pathogenic variants in PKP2 , the gene for the desmosomal protein plakophilin-2, are being enrolled in gene therapy trials designed to replace the defective allele via adeno-associated viral transduction of cardiac myocytes. Evidence from experimental systems and patients indicates that ventricular myocytes in PKP2 arrhythmogenic cardiomyopathy have greatly reduced electrical coupling at gap junctions and reduced Na + current density. In previous adeno-associated viral gene therapy trials,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyPlakophilinsMyocytes, CardiacComputer SimulationArrhythmogenic Right Ventricular DysplasiaModels, CardiovascularHeart Conduction SystemArrhythmias, CardiacHumansAction Potentials

Stichwörter der Autor:innen

cardiomyopathiescomputer simulationgenetic therapyheart blockplakophilins

Substanzen

PlakophilinsPKP2 protein, human

Autor:innen und Institutionen

  • Department of Physiology (A.O., J.P.K.), University of Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences (A.O.), University of Bern, Switzerland.
  • John A. Paulson School of Engineering and Applied Sciences, Harvard University, Boston, MA (A.G.K.).
  • Department of Biomedical Engineering, Washington University, St. Louis, MO (Y.R.).
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (J.E.S.).

ORCID-Profile: André G Kléber, Yoram Rudy, Jeffrey E Saffitz, Jan P Kucera

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Ostini, A., Kléber, A. G., Rudy, Y., Saffitz, J. E., & Kucera, J. P. (2025). Computational Modeling of Effects of PKP2 Gene Therapy on Ventricular Conduction Properties in Arrhythmogenic Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology, 18(5). https://doi.org/10.1161/circep.124.013658

Vancouver

Ostini A, Kléber AG, Rudy Y, Saffitz JE, Kucera JP. Computational Modeling of Effects of PKP2 Gene Therapy on Ventricular Conduction Properties in Arrhythmogenic Cardiomyopathy. Circulation: Arrhythmia and Electrophysiology. 2025;18(5). doi:10.1161/circep.124.013658

BibTeX
@article{Ostini2025,
  author = {Ostini, Alessio and Kléber, André G and Rudy, Yoram and Saffitz, Jeffrey E and Kucera, Jan P},
  title = {Computational Modeling of Effects of PKP2 Gene Therapy on Ventricular Conduction Properties in Arrhythmogenic Cardiomyopathy},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2025},
  volume = {18},
  number = {5},
  doi = {10.1161/circep.124.013658}
}
Kostenlos starten →